Literature DB >> 22831979

A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder.

Brian P Brennan1, Scott L Rauch, J Eric Jensen, Harrison G Pope.   

Abstract

Functional neuroimaging studies have converged to suggest that cortico-striatal-thalamo-cortical (CSTC) circuit dysfunction is a core pathophysiologic feature of obsessive-compulsive disorder (OCD). Now, complementary approaches examining regional neurochemistry are beginning to yield additional insights with regard to the neurobiology of aberrant CSTC circuitry in OCD. In particular, proton magnetic resonance spectroscopy, which allows for the in vivo quantification of various neurochemicals in the CSTC circuit and other brain regions, has recently been used extensively in studies of OCD patients. In this review, we summarize the diverse and often seemingly inconsistent findings of these studies, consider methodological factors that might help to explain these inconsistencies, and discuss several convergent findings that tentatively seem to be emerging. We conclude with suggestions for possible future proton magnetic resonance spectroscopy studies in OCD.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22831979      PMCID: PMC3504626          DOI: 10.1016/j.biopsych.2012.06.023

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  100 in total

1.  MRSI correlates of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.

Authors:  Joseph O'Neill; John C Piacentini; Susanna Chang; Jennifer G Levitt; Michelle Rozenman; Lindsey Bergman; Noriko Salamon; Jeffry R Alger; James T McCracken
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-10-01       Impact factor: 5.067

2.  Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

Authors:  D L Arnold; P M Matthews; G S Francis; J O'Connor; J P Antel
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

3.  Creatine abnormalities in schizophrenia and bipolar disorder.

Authors:  Dost Ongür; Andrew P Prescot; J Eric Jensen; Bruce M Cohen; Perry F Renshaw
Journal:  Psychiatry Res       Date:  2009-02-23       Impact factor: 3.222

4.  Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography.

Authors:  S L Rauch; M A Jenike; N M Alpert; L Baer; H C Breiter; C R Savage; A J Fischman
Journal:  Arch Gen Psychiatry       Date:  1994-01

5.  Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.

Authors:  Ethan A Smith; Aileen Russell; Elisa Lorch; S Preeya Banerjee; Michelle Rose; Jennifer Ivey; Rashmi Bhandari; Gregory J Moore; David R Rosenberg
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

6.  Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder.

Authors:  Aileen Russell; Bernadette Cortese; Elisa Lorch; Jennifer Ivey; S Preeya Banerjee; Gregory J Moore; David R Rosenberg
Journal:  J Child Adolesc Psychopharmacol       Date:  2003       Impact factor: 2.576

7.  Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Authors:  S Evelyn Stewart; Jesen A Fagerness; Jill Platko; Jordan W Smoller; Jeremiah M Scharf; Cornelia Illmann; Eric Jenike; Nadia Chabane; Marion Leboyer; Richard Delorme; Michael A Jenike; David L Pauls
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

Review 8.  Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature.

Authors:  S E Stewart; D A Geller; M Jenike; D Pauls; D Shaw; B Mullin; S V Faraone
Journal:  Acta Psychiatr Scand       Date:  2004-07       Impact factor: 6.392

9.  Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder.

Authors:  David Mataix-Cols; Sarah Wooderson; Natalia Lawrence; Michael J Brammer; Anne Speckens; Mary L Phillips
Journal:  Arch Gen Psychiatry       Date:  2004-06

10.  Meta-analysis of brain volume changes in obsessive-compulsive disorder.

Authors:  Jean-Yves Rotge; Dominique Guehl; Bixente Dilharreguy; Jean Tignol; Bernard Bioulac; Michele Allard; Pierre Burbaud; Bruno Aouizerate
Journal:  Biol Psychiatry       Date:  2008-08-21       Impact factor: 13.382

View more
  44 in total

1.  Abnormal brain activation in excoriation (skin-picking) disorder: evidence from an executive planning fMRI study.

Authors:  Brian L Odlaug; Adam Hampshire; Samuel R Chamberlain; Jon E Grant
Journal:  Br J Psychiatry       Date:  2015-07-09       Impact factor: 9.319

Review 2.  Pharmacological treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; Michael H Bloch
Journal:  Psychiatr Clin North Am       Date:  2014-07-24

3.  Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.

Authors:  Joseph O'Neill; John Piacentini; Susanna Chang; Ronald Ly; Tsz M Lai; Casey C Armstrong; Lindsey Bergman; Michelle Rozenman; Tara Peris; Allison Vreeland; Ross Mudgway; Jennifer G Levitt; Noriko Salamon; Stefan Posse; Gerhard S Hellemann; Jeffry R Alger; James T McCracken; Erika L Nurmi
Journal:  Neuropsychopharmacology       Date:  2017-04-04       Impact factor: 7.853

4.  An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.

Authors:  Brian P Brennan; Olga Tkachenko; Zachary J Schwab; Richard J Juelich; Erin M Ryan; Alison J Athey; Harrison G Pope; Michael A Jenike; Justin T Baker; William D S Killgore; James I Hudson; J Eric Jensen; Scott L Rauch
Journal:  Neuropsychopharmacology       Date:  2015-02-09       Impact factor: 7.853

5.  1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.

Authors:  Raşit Tükel; Kubilay Aydın; Erhan Ertekin; Seda Şahin Özyıldırım; Mehmet Barburoğlu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-26       Impact factor: 5.270

Review 6.  Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.

Authors:  David L Pauls; Amitai Abramovitch; Scott L Rauch; Daniel A Geller
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

7.  Treatment Efficacy of Combined Sertraline and Guanfacine in Comorbid Obsessive-Compulsive Disorder and Attention Deficit/Hyperactivity Disorder: Two Case Studies.

Authors:  Shibany P Taormina; Matthew P Galloway; David R Rosenberg
Journal:  J Dev Behav Pediatr       Date:  2016 Jul-Aug       Impact factor: 2.225

Review 8.  Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.

Authors:  Isaac Zike; Tim Xu; Natalie Hong; Jeremy Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2016-09-16       Impact factor: 3.590

Review 9.  Neuroimaging for psychotherapy research: current trends.

Authors:  Carol P Weingarten; Timothy J Strauman
Journal:  Psychother Res       Date:  2014-02-17

Review 10.  Obsessive-compulsive disorder.

Authors:  Dan J Stein; Daniel L C Costa; Christine Lochner; Euripedes C Miguel; Y C Janardhan Reddy; Roseli G Shavitt; Odile A van den Heuvel; H Blair Simpson
Journal:  Nat Rev Dis Primers       Date:  2019-08-01       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.